9-(Tetrahydro-2H-pyran-2-yloxy)-7-nonynoic acid
|
- $148 - $691.27
- Product name: 9-(Tetrahydro-2H-pyran-2-yloxy)-7-nonynoic acid
- CAS: 957761-18-1
- MF: C14H22O4
- MW: 254.32
- EINECS:
- MDL Number:MFCD09836212
- Synonyms:9-(Tetrahydro-2H-pyran-2-yloxy)-7-nonynoic acid;9-(oxan-2-yloxy)non-7-ynoic acid;7-Nonynoic acid, 9-[(tetrahydro-2H-pyran-2-yl)oxy]-
3 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 250mg
- ManufacturerAK Scientific
- Product number0513AQ
- Product description9-(Tetrahydro-2H-pyran-2-yloxy)-7-nonynoic acid
- Packaging250mg
- Price$244
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0115693
- Product description9-(TETRAHYDRO-2H-PYRAN-2-YLOXY)-7-NONYNOIC ACID 95.00%
- Packaging250MG
- Price$691.27
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number666645
- Product description9-(Tetrahydro-2H-pyran-2-yloxy)-7-nonynoic acid 95%
- Packaging250mg
- Price$148
- Updated2023-01-07
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 0513AQ | 9-(Tetrahydro-2H-pyran-2-yloxy)-7-nonynoic acid | 250mg | $244 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0115693 | 9-(TETRAHYDRO-2H-PYRAN-2-YLOXY)-7-NONYNOIC ACID 95.00% | 250MG | $691.27 | 2021-12-16 | Buy |
| Sigma-Aldrich | 666645 | 9-(Tetrahydro-2H-pyran-2-yloxy)-7-nonynoic acid 95% | 250mg | $148 | 2023-01-07 | Buy |
Properties
Boiling point :429.9±45.0 °C(Predicted)
Density :1.081 g/mL at 25 °C
refractive index :n20/D 1.484
Flash point :110 °C
storage temp. :2-8°C
pka :4.74±0.10(Predicted)
Density :1.081 g/mL at 25 °C
refractive index :n20/D 1.484
Flash point :110 °C
storage temp. :2-8°C
pka :4.74±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||
| Hazard statements: |
|
||||||||||||||
| Precautionary statements: |
|